Lung cancer
1L metastatic/recurrent NSCLC (with chemo)1
Lung cancer
1L metastatic/recurrent NSCLC (with chemo)1
1L, first-line; AUC, area under the curve; chemo, chemotherapy; IV, intravenous; NSCLC, non-small cell lung cancer; PD, progressive disease; Pt, platinum; QxW, every x weeks.
1. Opdivo® (nivolumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb; 2023.
2. Data on file. NIVO 608. Princeton, NJ: Bristol Myers Squibb Company; 2020.
2. Data on file. NIVO 608. Princeton, NJ: Bristol Myers Squibb Company; 2020.